ID25516A - COMPOUNDS CONTAINING SIX-RING RINGS, THE PROCESS OF MAKING IT, AND USING IT AS A MEDICINE - Google Patents
COMPOUNDS CONTAINING SIX-RING RINGS, THE PROCESS OF MAKING IT, AND USING IT AS A MEDICINEInfo
- Publication number
- ID25516A ID25516A IDW20000543A ID20000543A ID25516A ID 25516 A ID25516 A ID 25516A ID W20000543 A IDW20000543 A ID W20000543A ID 20000543 A ID20000543 A ID 20000543A ID 25516 A ID25516 A ID 25516A
- Authority
- ID
- Indonesia
- Prior art keywords
- medicine
- making
- compounds containing
- ring rings
- rings
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/52—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5930897P | 1997-09-17 | 1997-09-17 | |
US93864497A | 1997-09-26 | 1997-09-26 | |
US6019597P | 1997-09-26 | 1997-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID25516A true ID25516A (en) | 2000-10-05 |
Family
ID=27369627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20000543A ID25516A (en) | 1997-09-17 | 1998-09-15 | COMPOUNDS CONTAINING SIX-RING RINGS, THE PROCESS OF MAKING IT, AND USING IT AS A MEDICINE |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1015417A1 (en) |
JP (1) | JP2001516739A (en) |
KR (1) | KR20010024123A (en) |
CN (1) | CN1272105A (en) |
AR (1) | AR013960A1 (en) |
AU (1) | AU747702B2 (en) |
BR (1) | BR9812649A (en) |
CA (1) | CA2303323A1 (en) |
EA (1) | EA003989B1 (en) |
ID (1) | ID25516A (en) |
IL (1) | IL134691A0 (en) |
IN (1) | IN190983B (en) |
NZ (1) | NZ502988A (en) |
TR (1) | TR200000723T2 (en) |
WO (1) | WO1999014185A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1282316A (en) * | 1997-12-17 | 2001-01-31 | 生物晶体药品股份有限公司 | Substituted cyslopentane and cyclopentene compounds useful as neuraminidase inhibitors |
US6455571B1 (en) | 1998-04-23 | 2002-09-24 | Abbott Laboratories | Inhibitors of neuraminidases |
US6518305B1 (en) | 1998-04-23 | 2003-02-11 | Abbott Laboratories | Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
ATE241589T1 (en) * | 1999-06-11 | 2003-06-15 | Hoffmann La Roche | METHOD FOR PRODUCING THE NEURAMINIDASE INHIBITOR RO-64-0796 |
BR0010525A (en) * | 1999-10-19 | 2002-11-26 | Abbott Lab | 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1carboxylates as neuraminidase inhibitors |
US6593314B1 (en) | 1999-10-19 | 2003-07-15 | Abbott Laboratories | Neuraminidase inhibitors |
JP2001131144A (en) * | 1999-11-02 | 2001-05-15 | Sagami Chem Res Center | Method for producing 7-azabicyclo[4.1.0]hept-3-ene-3- carboxylate compounds |
US6403824B2 (en) * | 2000-02-22 | 2002-06-11 | Hoffmann-La Roche Inc. | Process for the preparation for 4,5-diamino shikimic acid derivatives |
AU2001252578A1 (en) * | 2000-04-25 | 2001-11-07 | Sankyo Company Limited | Preventives for influenza |
WO2002092555A1 (en) * | 2001-05-11 | 2002-11-21 | Sankyo Company, Limited | Sialic acid derivatives |
US7122684B2 (en) | 2003-03-13 | 2006-10-17 | Roche Colorado Corporation | Process for preparing 1,2-diamino compounds |
CN101351438A (en) * | 2005-12-28 | 2009-01-21 | 弗·哈夫曼-拉罗切有限公司 | Epoxide intermediate in the tamiflu synthesis |
US8334319B2 (en) * | 2008-01-04 | 2012-12-18 | Roche Palo Alto Llc | Polymorphic forms of oseltamivir phosphate |
EP2499201B1 (en) * | 2009-11-11 | 2017-05-10 | 3M Innovative Properties Company | Polymeric compositions and method of making and articles thereof |
DE102011117128A1 (en) | 2011-10-28 | 2013-05-02 | Christian-Albrechts-Universität Zu Kiel | Compounds for the treatment of influenza |
RU2469020C1 (en) * | 2011-11-08 | 2012-12-10 | Александр Васильевич Иващенко | (3r,4r,5s)-4-acylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-ene-carboxylic acids, their esters and method for using |
CN102659615B (en) * | 2012-05-09 | 2014-05-07 | 中国药科大学 | Derivatives of oseltamivir, and preparation method and medical application thereof |
RU2520836C1 (en) * | 2013-02-27 | 2014-06-27 | Александр Васильевич Иващенко | (3r,4r,5s)-4-amino-5-(2,2-difluoroacetylamino)-3-(1-ethylpropoxy)-cyclohex-1-enecarboxylic acid and its ethers, method of obtaining and applying thereof |
RU2633085C2 (en) * | 2014-05-20 | 2017-10-11 | Российская Федерация, от имени которой выступает Федеральное государственное казенное учреждение "Войсковая часть 68240" | Antiviral drug as capsules and method for its preparation |
CN105439884A (en) * | 2015-10-27 | 2016-03-30 | 沈阳药科大学 | Oseltamivir preparation method |
CN108047076B (en) * | 2017-12-26 | 2020-05-08 | 杭州新博思生物医药有限公司 | Preparation method of oseltamivir enantiomer |
CN110194728B (en) * | 2019-06-19 | 2021-04-30 | 湖南华腾制药有限公司 | Continuous synthesis method of oseltamivir phosphate intermediate |
CN114057599A (en) * | 2020-07-29 | 2022-02-18 | 广州市恒诺康医药科技有限公司 | Neuraminidase inhibitor compound, pharmaceutical composition and application thereof |
CN116375595A (en) * | 2023-03-31 | 2023-07-04 | 重庆医药高等专科学校 | Preparation method and refining method of oseltamivir phosphate |
CN116666669B (en) * | 2023-07-25 | 2023-10-03 | 四川大学 | VN-supported Ir cluster, preparation method thereof and application thereof in catalyst |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK282950B6 (en) * | 1990-04-24 | 2003-01-09 | Biota Scientific Management Pty Ltd | Alpha-D-neuraminic acid derivatives, their preparation method, use and pharmaceutical preparations based on them |
WO1992006691A1 (en) * | 1990-10-19 | 1992-04-30 | Biota Scientific Management Pty. Ltd. | Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus |
DE69607704T2 (en) * | 1995-02-27 | 2000-12-28 | Gilead Sciences, Inc. | NEW SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDAS |
US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
MXPA99001697A (en) * | 1996-08-23 | 2004-04-05 | Gilead Sciences Inc | Preparation of cyclohexene carboxylate derivatives. |
-
1998
- 1998-09-15 CA CA002303323A patent/CA2303323A1/en not_active Abandoned
- 1998-09-15 JP JP2000511738A patent/JP2001516739A/en not_active Withdrawn
- 1998-09-15 TR TR2000/00723T patent/TR200000723T2/en unknown
- 1998-09-15 WO PCT/US1998/019355 patent/WO1999014185A1/en not_active Application Discontinuation
- 1998-09-15 NZ NZ502988A patent/NZ502988A/en not_active IP Right Cessation
- 1998-09-15 AU AU95694/98A patent/AU747702B2/en not_active Expired
- 1998-09-15 EA EA200000332A patent/EA003989B1/en not_active IP Right Cessation
- 1998-09-15 EP EP98949356A patent/EP1015417A1/en not_active Ceased
- 1998-09-15 ID IDW20000543A patent/ID25516A/en unknown
- 1998-09-15 CN CN98809320A patent/CN1272105A/en active Pending
- 1998-09-15 IL IL13469198A patent/IL134691A0/en not_active IP Right Cessation
- 1998-09-15 BR BR9812649-0A patent/BR9812649A/en not_active Application Discontinuation
- 1998-09-15 KR KR1020007002880A patent/KR20010024123A/en not_active Application Discontinuation
- 1998-09-17 IN IN2791DE1998 patent/IN190983B/en unknown
- 1998-09-17 AR ARP980104638A patent/AR013960A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU747702B2 (en) | 2002-05-16 |
IL134691A0 (en) | 2001-04-30 |
NZ502988A (en) | 2002-08-28 |
EA200000332A1 (en) | 2000-10-30 |
CN1272105A (en) | 2000-11-01 |
IN190983B (en) | 2003-09-06 |
KR20010024123A (en) | 2001-03-26 |
BR9812649A (en) | 2000-08-22 |
EP1015417A1 (en) | 2000-07-05 |
JP2001516739A (en) | 2001-10-02 |
AR013960A1 (en) | 2001-01-31 |
TR200000723T2 (en) | 2001-06-21 |
AU9569498A (en) | 1999-04-05 |
CA2303323A1 (en) | 1999-03-25 |
WO1999014185A1 (en) | 1999-03-25 |
EA003989B1 (en) | 2003-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID25516A (en) | COMPOUNDS CONTAINING SIX-RING RINGS, THE PROCESS OF MAKING IT, AND USING IT AS A MEDICINE | |
ID21045A (en) | MODIFIED AMINO ACID, THE DRUGS CONTAINING THIS COMPOUND AND THE PROCESS OF MAKING IT | |
ID26589A (en) | 4-HALOALKYL -3-HETEROSICLYLPIRIDINE AND 4- HALOALKYL-5-HETEROSICLYLPIRIMIDINE PROCESS FOR THE MAKING OF A COMPOSITION CONSTITUTING OF IT AND THE USE OF IT AS A PESTICIDE | |
ID22821A (en) | SULFONAMIDA DERIVES, THE PROCESS OF MAKING AND USING IT AS A MEDICINE | |
ID26207A (en) | SUBSTITUTED ESTRATRIENA 11β-HALOGEN-7 αTERSUBSTITUTATION, PROCESS FOR PRODUCING PHARMACEUTICAL PROPERTIES CONTAINING ESTRATRIENA 11β-HALOGEN-7 αINII AND ALSO USE FOR PHARMACEUTICAL PRODUCTION CONTAINING | |
ID18613A (en) | NEW OXADIAZOL, THE PROCESS OF MAKING IT AND THE USE AS A PHARMACEUTICAL COMPOSITION | |
NO20021714L (en) | 2-Phenyl-substituted imidazotriazinones, process for their preparation and use of the compounds | |
ID26399A (en) | DEGREE 1- (1-SUBSTITUTED-4-PIPERIDINYL) METHYL-4-PIPERIDIN, THE PROCESS OF MAKING, PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUNDS, AND THEIR INTERMEDIETY | |
ID16128A (en) | NEW ARILGLICINAMIDE DEPOSITS, THE PROCESS OF MAKING AND PHARMACY COMPOSITION THAT CONTAINS THIS COMPOUND | |
ID27558A (en) | NEW AROMATIC AMIDES, THE METHOD OF MAKING IT AND USING IT AS A MEDICINE | |
ID21393A (en) | BENZAZEPINON-N-SUBSTITUTED-PHOSPHONEATE ACID, PRODUCTION PROCESS AND MEDICINES CONTAINING THIS COMPOUND | |
ID24714A (en) | SUBSTITUTION OF TIAZOLIDINDION DERIVATES, THE PROCESS OF PRODUCTION AND USE OF THE PHARMACEUTICAL MATERIALS | |
ID20604A (en) | SYNTHETIC POLICAKARIDA PROCESS FOR THE MAKING AND COMPOSITION OF THE PHARMACY CONTAINED | |
ID24070A (en) | THE CATALYST CONTAINING HOLOGIST AND THE PROCESS OF MAKING IT | |
ID20137A (en) | PROPANOLAMINA DECREASED, THE PROCESS OF MAKING, PHARMACEUTICAL PROPERTIES THAT CONTAIN THIS COMPOUND, AND ITS USE | |
ID17810A (en) | NEW SUBSTITUTED 2,4-TIAZOLIDINDION DOCUMENTS, PROCESSES FOR THE PRODUCTION AND PHARMACY COMPOSITION WHICH CONTAINS IT | |
PL340372A1 (en) | Novel 3,6x-hemiketals of 9a-azalydes class | |
ID22911A (en) | NEW TRIAZOL DISTRICTS, THE PROCESS OF MAKING AND THE PHARMACY COMPOSITION CONTAINING IT | |
ID20624A (en) | PROCESS OF MAKING 2'-FLOURO-5-METHYL-BETHA-L-RABINOFURANOSILURIDIN | |
ID24173A (en) | 1,2,3,4,5,6 HEKSAHIDRO-2-6-METANO-3-BENZAZOSIN-10-OL, THE PROCESS OF MAKING AND USING IT FOR MEDICINES | |
ID16794A (en) | PROCESS OF PURE ENANTIOMERIC PREPARATION OF CYCALOALO-INDOL-AND AZAINDOL-AND PYRIMIDO {1,2a} | |
ID20967A (en) | CHRISTANTS SUBSTITUTED SULFONAMIDE, THE PROCESS OF MAKING, USE AS A MEDICINE, AND PHARMACEUTICAL PROPERTIES THAT CONTAIN SUCH MATERIALS | |
EE200000055A (en) | Process for the preparation of cyclopropylacetylene | |
ID21209A (en) | SULFONAMIDE-SUBSTITUTED BENZOPIRAN DEPOSITS, THE PROCESS OF MAKING, USE AS A MEDICINE, AND PHARMACEUTICAL PROPERTIES THAT CONTAIN SUCH COMPOUND | |
PL324588A1 (en) | Novel compounds-substituted piperydinodiones-2,6, method of obtaining them and drug containing such compounds |